Neurogene Inc.

NasdaqGM:NGNE Stock Report

Market Cap: US$301.0m

Neurogene Inc. Company Information

Neurogene Inc.'s employee growth, exchange listings and data sources

Key Information

  • Name: Neurogene Inc.
  • Ticker: NGNE
  • Exchange: NasdaqGM
  • Founded: NaN
  • Industry: Biotechnology
  • Sector: Pharmaceuticals & Biotech
  • Market Cap: US$301.021m
  • Shares Outstanding: 14.83m
  • Website: https://www.neurogene.com

Number of Employees

Location

  • Neurogene Inc.
  • 535 W 24th Street
  • 5th Floor
  • New York
  • New York
  • 10011
  • United States

Listings

TickerExchangePrimary SecuritySecurity TypeCountryCurrencyListed on
NGNENasdaqGM (Nasdaq Global Market)YesCommon StockUSUSDDec 2023
UU8BST (Boerse-Stuttgart)YesCommon StockDEEURDec 2023
UU8DB (Deutsche Boerse AG)YesCommon StockDEEURDec 2023

Company Analysis and Financial Data Status

All financial data provided by Standard & Poor's Capital IQ.
DataLast Updated (UTC time)
Company Analysis2024/11/24 16:05
End of Day Share Price 2024/11/22 00:00
Earnings2024/09/30
Annual Earnings2023/12/31


Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.